Test Tubes Filled With Money

Pfizer Buys Cancer Drug Maker Medivation

Forget those early- to mid-stage clinical candidates. Pfizer Inc. (NYSE: PFE) jumped the line with its $13.5 billion deal for oncology drug maker Medivation Inc. (NASDAQ: MDVN). The target’s primary product is XTANDI® (enzalutamide), an androgen receptor inhibitor, the leading novel hormone therapy for the treatment of prostate cancer. Pfizer will pay $81.50 per share in...

This content is for Health Care M&A Membership and Health Care 60 Day Free Trial members only.
Log In Free Trial


Emergency Room

Jefferson Health Adds Another Health System

Jefferson Health System, the not-for-profit system that is part of Thomas Jefferson University Hospitals, signed a definitive agreement to integrate with Kennedy Health, a three-hospital system (607 beds) in southern New Jersey. The transaction is expected to be completed following New Jersey’s Community Health Care Assets Protection Act review process. The boards of Kennedy and Jefferson unanimously […]


pills an pill bottle on white background

Specialty Pharmacy Extends Reach in Healthcare

Genoa, a QoL Healthcare Company, a leading behavioral health specialty pharmacy company, has acquired the behavioral health and residential care services division of Advanced Care Pharmacy Services, including 13 of its pharmacies in Michigan. Genoa is a portfolio company of Advent International. In November 2015, Genoa acquired 1DocWay, the nation’s largest outpatient telepsychiatry provider, for […]


SANTA CLARITA CA/USA - DECEMBER 14 2014: AFC Doctors Express building exterior. AFC/Doctors Express is a medical franchise composed of urgent care clinics and primary health clinics.

Arizona Urgent Care Market Tightens

Banner Health just threw its hat in the ring for the title of largest urgent care operator in Arizona. The not-for-profit health system, which operates 29 hospitals in seven states, just announced its acquisition of 32 Urgent Care Extra facilities in that state, primarily around Phoenix and Tucson. The clinics will be rebranded as Banner Urgent […]

Genetic Codes

Myriad Genetics Eyes GeneSight

Myriad Genetics Inc. (NASDAQ: MYGN), which specializes in molecular diagnostics and personalized medicine, started off August with the acquisition of privately-held Assurex Health Inc., an informatics-based, personalized medicine company that specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, for behavioral health and chronic pain conditions. Assurex was […]


Scintilla Goes Deep into Pain Management

Scintilla Pharmaceuticals, Inc., a subsidiary of Sorrento Therapeutics Inc. (NASDAQ: SRNE), is spending up to $270 million to expand its pain management pipeline. On August 8, Scintilla announced its purchase of SCILEX Pharmaceuticals, Inc. for an upfront payment of $70 million. Scilex’s lead product candidate, ZTildo™ (lidocaine patch 1.8%) is being developed for the treatment of […]


Patient Experience Data Draws Big Money

EQT, a Swedish private equity firm with approximately €30 billion in raised capital, announced it was taking Press Ganey Holdings (NYSE: PGND) private with a purchase price of $2.35 billion, or $40.50 a share. Press Ganey made its mark by offering patient experience solutions to measure and analyze data collected directly from patients, including patient experience insights measured through several electronic […]

First Half of 2016 Shows Strength in M&A

Ever since the rally in health care mergers and acquisitions began in 2014, we’ve been waiting for the inevitable slam-on-the-brakes quarter. That rally was sparked by the advent of newly insured families and individuals entering the healthcare market, beginning on January 1, 2014. Thanks to the Affordable Care Act, passed in 2010, health care M&A...

This content is for Health Care M&A Membership and Health Care 60 Day Free Trial members only.
Log In Free Trial